A leading cause of morbidity and mortality worldwide, ischemic heart diseases develop when insufficient blood supply to the heart muscle compromises its function. The condition often stems from plaque buildup within the coronary arteries, reducing oxygen delivery and causing ischemic damage. Patients may experience silent symptoms or acute events such as angina or myocardial infarction. Effective management of ischemic heart diseases combines risk factor control, such as smoking cessation and cholesterol management, with advanced medical and surgical treatments. Modern cardiology continues to refine techniques to restore and preserve heart function, offering hope to millions affected by this condition. Raising awareness and promoting preventive strategies remain critical in reducing the global burden of this disease.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States